Matthew Shields

EVP, Global Operations, Teva Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$1.4M

Companies

Latest trade

Jun 18, 2026

Companies

Teva PharmaceuticalsEVP, Global Operations −$1.4M

Trades

TEVA Sold 9,989 shares at $32.19 $0.3M Jun 18

TEVA Sold 16,195 shares at $32.87 · planned $0.5M Jun 3

TEVA Sold 17,295 shares at $31.67 · planned $0.5M Mar 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.